Red clover mottle virus (RCMV) is a member of the comovirus group of plant viruses. Its genome consists of two molecules of positive-strand (messenger-sense) RNA which are encapsidated separately in isometric particles termed middle (M) and bottom (B) components. Three distinct strains of RCMV, S, N and O, have been described, and these differ in host range and symptomatology (Oxelfelt, 1976) . In the case of strain S, both RNAs have been shown to be polyadenylated (Oxelfelt, 1976; Shanks et al., 1986) , and the M RNA has been shown to have a small protein (VPg) linked to its 5' end. We have previously determined the complete nucleotide sequence of the M RNA of RCMV strain S (Shanks et al., 1986) and the sequence of a 771 nucleotide portion of the B RNA sequence which allowed us to deduce the amino acid sequence of the virus-encoded protease (the 24K protease) and the VPg (Shanks & Lomonossoff, 1990) . In this paper we report the complete nucleotide sequence of B RNA, thereby completing the sequence of the entire genome of RCMV strain S.
The construction of cDNA clones specific for the 3'-terminal 4-5 kb of the B RNA of RCMV strain S has been described previously (Shanks & Lomonossoff, 1990) . The clones, including Sma/Pst-2 and Taq-7, the partial sequences of which have already been reported (Shanks & Lomonossoff, 1990) , were sequenced using the dideoxynucleotide method (Biggin et al., 1983) either directly or after subcloning restriction enzyme fragments derived from them into bacteriophage M13 vectors. In this way, the sequence of 4373 nucleotides extending from the PstI site at the left end of clone Sma/Pst-2 (position 1660 of the final sequence) to the 3' end of the B The nucleotide sequence data reported here have been submitted to the EMBL database and assigned the accession number X64886.
0001-1010 © 1992 SGM RNA was determined. To obtain further sequence data, double-stranded cDNA was synthesized as described previously for M RNA (Shanks et al., 1986) using the oligonucleotide d(GGTATTTTCCTAACACC), complementary to nucleotides 1680 to 1696 of the B RNA sequence, as a primer for first-strand synthesis. The resultant cDNA was digested with a variety of restriction enzymes, and the fragments were cloned into appropriately linearized bacteriophage M 13 vectors. Analysis of the resulting clones enabled the sequence of all but the 5'-terminal 33 nucleotides to be determined.
To complete the sequence of B RNA, the oligonucleotide d(GTCTCAAGCAGAAAAGAGAG), complementary to nucleotides 67 to 86 of the final sequence, was kinase-labelled and used to prime cDNA synthesis in the presence of dideoxynucleoside triphosphates (Meshi et al., 1983) . The sequence obtained enabled all but the extreme Y-terminal base to be identified. This was identified by labelling the VPg presumed to be attached to the 5' terminus of B RNA with 125I as described previously (Lomonossoff et al., 1985) , and digesting the labelled RNA with a variety of specific nucleases. The digests were analysed by electrophoresis on SDSpolyacrylamide gels and the identity of the Y-terminal base was deduced as described previously for RCMV M RNA (Shanks et al., 1986) . The results obtained confirmed the presence of the VPg at the 5' end of B RNA and showed that the 5'-terminal residue of B RNA is a U (data not shown).
The complete nucleotide sequence of B RNA from RCMV strain S is shown in Fig. 1 , and is 6033 nucleotides long, excluding the poly(A) tail. Apart from the 5'-terminal 33 bases, the entire sequence was determined in both directions using cDNA clones and each base was sequenced 3.5 times on average. In CdUGC  C  ~CAAGGC2~AUA~ JC0~O  4450  4470  4490  4510  4530 4550 
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CULt%AC, AGAU CUUCAGUACU~CGCAC ~ 5050 5070 5090 5110 5130 5150 CCOJC~CCACAAUGACA6~CUUGA~~CtL~CUAGGACCAGCAAUCCUGG  5290  5310  5330  5350 5370 5390 (Davies et al., 1979) . Comparison of the sequence reported here with that of M RNA shows that the 5'-terminal sequences of the RNAs are also very similar, with 50 of the first 55 residues being identical. RCMV B RNA also possesses the 5' structure VPg-UAUUAAAAU which is common to all comovirus RNAs sequenced to date (Stanley & van Kammen, 1979; Shanks et al., 1986; MacFarlane et al., 1991) .
Inspection of the B RNA sequence reveals the presence of a single long open reading frame (ORF) beginning with an AUG codon at position 270 and terminating with a UGA codon at position 5862. This ORF is sufficient to encode a protein of 1864 amino acids with a calculated Mr of 210258. Unlike the situation found for CPMV B RNA, the AUG at the start of the long ORF is not the 5' proximal one, an upstream out-ofphase AUG occurring at position 14. This AUG is in phase with a UAA termination codon at position 92 and thus could direct the synthesis of an oligopeptide of only 26 amino acids. Also, in contrast to the situation found with CPMV B RNA, the AUG that commences the long ORF is not in an optimal context despite having an A residue at the -3 position (Liitcke et al., 1986) because it has a U rather than the optimal G residue at the +4 position. Both these features might be expected to reduce the efficiency of translation of RCMV B RNA in comparison with that of the B RNA from CPMV. Comparison of the amino acid sequences encoded by the long ORFs of the B RNAs of CPMV and RCMV reveals that they are clearly homologous. As calculated by the Gap program (Devereux et al., 1984) , the proteins are 56.6% identical, a figure which rises to 74.7% when similarities in amino acids are taken into account. The similarities between these B RNA-encoded polyproteins strongly suggest that they will undergo a similar pattern of proteolytic processing, and it was on this basis that the potential cleavage sites between the RCMV equivalents of the CPMV B RNA-encoded 58K protein, VPg, 24K protease and 87K protein were deduced (Shanks & Lomonossoff, 1990) . The data presented here now allow the potential cleavage site between the RCMV equivalents of the CPMV B RNA-encoded 32K and 58K proteins to be assigned (Fig. 1) . All the cleavage sites identified in the RCMV B RNA-encoded polyprotein have glutamine (Q) at the -1 position and alanine at the -2 position, and either glycine (G), serine (S) or methionine (M) at the + 1 position. In this respect they closely resemble the cleavage sites found in the CPMV B RNA-encoded polyprotein, except that the latter have either alanine or proline at the -2 position (Lomonossoft & Shanks, 1983; Wellink et aL, 1986) .
Assuming the cleavage sites within the RCMV B RNA-encoded polyprotein have been correctly identified, the sizes of the individual B RNA-encoded proteins et al., 1984) with a gap weight of 3-00 and a gap length weight of 1-00.
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§ Figures for the equivalent CPMV proteins are shown in parentheses.
can be calculated and their homology to their CPMV counterparts assessed (Table 1 ). The motifs associated with nucleotide binding, the proteolytic activity and the RNA-dependent RNA polymerase activity found in the CPMV 58K, 24K and 87K proteins, respectively, are strictly conserved in the equivalent RCMV proteins. The protein with the least similarity to its CPMV counterpart is the 32K protein, a protein which, in the case of CPMV, has been shown to act as a cofactor enabling the 24K protease to cleave the M RNA-encoded polyproteins (Vos et al., 1988) . Though it had been demonstrated that the proteolytic activity associated with CPMV is unable to cleave the polyproteins encoded by the M RNA of RCMV (Goldbach & Krijt, 1982) , comparison of the sequences of the respective 24K proteases did not provide any explanation for this specificity (Shanks & Lomonossoff, 1990) . The comparatively low similarity between the 32K proteins of RCMV and CPMV makes it plausible that it may be this protein, rather than the 24K protease itself, which determines substrate specificity in regard to cleavage of the M RNA-encoded polyproteins.
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